John Hodgman - Net Worth and Insider Trading

John Hodgman Net Worth

The estimated net worth of John Hodgman is at least $551,028 dollars as of 2024-09-21. John Hodgman is the Director of Sarepta Therapeutics Inc and owns about 4,333 shares of Sarepta Therapeutics Inc (SRPT) stock worth over $551,028. Details can be seen in John Hodgman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John Hodgman has not made any transactions after 2013-09-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of John Hodgman

To

John Hodgman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, John Hodgman owns 2 companies in total, including Sarepta Therapeutics Inc (SRPT) , and Immersion Corp (IMMR) .

Click here to see the complete history of John Hodgman’s form 4 insider trades.

Insider Ownership Summary of John Hodgman

Ticker Comapny Transaction Date Type of Owner
SRPT Sarepta Therapeutics Inc 2013-09-03 director
IMMR Immersion Corp 2009-03-04 director

John Hodgman Latest Holdings Summary

John Hodgman currently owns a total of 1 stock. John Hodgman owns 4,333 shares of Sarepta Therapeutics Inc (SRPT) as of September 3, 2013, with a value of $551,028.

Latest Holdings of John Hodgman

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SRPT Sarepta Therapeutics Inc 2013-09-03 4,333 127.17 551,028

Holding Weightings of John Hodgman


John Hodgman Form 4 Trading Tracker

According to the SEC Form 4 filings, John Hodgman has made a total of 0 transactions in Sarepta Therapeutics Inc (SRPT) over the past 5 years. The most-recent trade in Sarepta Therapeutics Inc is the sale of 5,556 shares on September 3, 2013, which brought John Hodgman around $194,293.

Insider Trading History of John Hodgman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

John Hodgman Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

John Hodgman Ownership Network

Ownership Network List of John Hodgman

No Data

Ownership Network Relation of John Hodgman

Insider Network Chart

John Hodgman Owned Company Details

What does Sarepta Therapeutics Inc do?

Who are the key executives at Sarepta Therapeutics Inc?

John Hodgman is the director of Sarepta Therapeutics Inc. Other key executives at Sarepta Therapeutics Inc include Chief Financial Officer Ian Michael Estepan , Chief Tech Ops Officer Bilal Arif , and SVP & General Counsel Ryan Edward Brown .

Sarepta Therapeutics Inc (SRPT) Insider Trades Summary

Over the past 18 months, John Hodgman made no insider transaction in Sarepta Therapeutics Inc (SRPT). Other recent insider transactions involving Sarepta Therapeutics Inc (SRPT) include a net purchase of 105,570 shares made by Michael Andrew Chambers , a net sale of 40,957 shares made by Ryan Edward Brown , and a net sale of 30,000 shares made by Wigzell Hans Lennart Rudolf .

In summary, during the past 3 months, insiders sold 56,699 shares of Sarepta Therapeutics Inc (SRPT) in total and bought 37,038 shares, with a net sale of 19,661 shares. During the past 18 months, 99,430 shares of Sarepta Therapeutics Inc (SRPT) were sold and 180,795 shares were bought by its insiders, resulting in a net purchase of 81,365 shares.

Sarepta Therapeutics Inc (SRPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Sarepta Therapeutics Inc Insider Transactions

No Available Data

John Hodgman Mailing Address

Above is the net worth, insider trading, and ownership report for John Hodgman. You might contact John Hodgman via mailing address: C/o Immersion Corp, 801 Fox Ln., San Jose Ca 95131.

Discussions on John Hodgman

No discussions yet.